Whalehaven Capital Fund
VC Fund
Toronto, Canada
Whalehaven Capital Fund is a hedge fund that caters to companies in the U.S. and Canadian small cap marketplace.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Whalehaven Capital Fund invests in
Stages Whalehaven Capital Fund invests in
Countries Whalehaven Capital Fund invests in
Investment Focus
Industry
- Biotechnology 3 (75%)
- Medical 1 (25%)
- Software 1 (25%)
- Biopharma 1 (25%)
- Health Care 1 (25%)
Stage
- Funding Round 2 (50%)
- Post-IPO Equity 2 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Sevion Therapeutics
|
Sevion is a biopharmaceutical company which discovers, develops and acquires innovative product candidates for the treatment of cancer and immunological diseases. The Company is advancing a pipeline of proprietary and partnered product candidates that leverages its unique antibody technology platforms. The Company’s antibody pipeline is beingdeveloped from technology that allows for the discovery of innovative biologic therapies to previously inaccessible targets, such as multispanning membrane proteins and ion channels that play an important role in multiple diseases. The Company also developed the first protein nanocage system allowing delivery of nucleic acids and other payloads to target cells. | $11.5M / Post-IPO Equity / Mar 29, 2010 | |
CEL-SCI
|
CEL-SCI Corporation is a biotechnology company. CEL-SCI is involved in the research and development of immunotherapy products for the treatment of cancer and infectious diseases. The Company's core capabilities include: drug discovery, research, development and manufacturing of complex biological substances. | $4.4M / Post-IPO Equity / Aug 20, 2009 | |
Somanta Pharmaceuticals
|
Somanta Pharmaceuticals a development stage biopharmaceutical company, develops drugs primarily for the treatment of cancer. It holds a license to develop Sodium Phenylbutyrate for the treatment of cancer, autoimmune diseases, and other clinical indications. The company's products in the pre-clinical stage of development include Alchemix,which is intended to interrupt various phases of the cancer cell growth cycle by selectively binding to DNA and inhibiting DNA processing enzymes to overcome drug resistant tumors. | $3.7M / Jan 31, 2006 | |
BravoSolution
|
BravoSolution US provides on-demand supply management solutions to companies primarily in the United States and Europe. It offers various supply management software & services in areas, such as program management, spend analysis, eSourcing, contract management, and supplier performance management. The company was formerly known as VerticalnetInc. and changed its name to BravoSolution US in January 2008. The company was incorporated in 1995 and is based in Malvern, Pennsylvania. As of January 25, 2008, BravoSolution US operates as a subsidiary of BravoSolution SpA. | $6.5M / Aug 16, 2005 |
Co-Investors
Alpha Capital
4 deals together
Iroquois Capital
3 deals together
Midsummer Capital
2 deals together
ArmaVir Partners
2 deals together
BF Holdings
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Whalehaven Capital Fund invest in?
Whalehaven Capital Fund invests primarily in Biotechnology, Medical and Software startups, most often at Funding Round and Post-IPO Equity stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Whalehaven Capital Fund last invest?
The most recent investment recorded for Whalehaven Capital Fund closed in Mar 2010. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
